Moderna asked Food and Drug Administration (FDA) regulators on Thursday to authorize its COVID-19 vaccine for emergency use in children under 6 years of age.
company said the shot was about 51% effective against the virus for kids under 2 years old and about 37% effective in kids ages 2 to 5.
Dr. Salma Elfaki holds a vial of Moderna COVID-19 vaccine at a clinical trial for adolescents being conducted in Orlando on Sept. 25, 2021.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Moderna to ask FDA to authorize Covid-19 vaccine for young kidsThe request comes a month after the drug company signaled its two-dose regimen generated immune protection in the youngest children comparable to young adults.
Les mer »
Moderna Asks FDA to Approve Its COVID-19 Shot for Kids Under 6Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.
Les mer »
Moderna asks FDA to authorize first COVID-19 vaccine for very young childrenThe company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.
Les mer »
Moderna Asks FDA to Clear Its Covid-19 Vaccine for Young ChildrenModerna asked the FDA to authorize its Covid-19 vaccine for children 6 months to 5 years. If regulators agree, vaccinations could begin by summer.
Les mer »
Moderna seeks FDA approval for COVID vaccine for kids under 6Moderna submitted data that it hopes will prove two low-dose shots can protect babies, toddlers and preschoolers.
Les mer »
Moderna Asks FDA to Authorize Covid Vaccine for Kids Under 6 Years OldThe FDA has promised to move quickly to authorize shots for infants, toddlers and preschoolers once the vaccine makers submit complete applications.
Les mer »